Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Malate with Chemotherapy for Untreated Extensive Stage Small Cell Lung Cancer
NCT00453154Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2007
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Mar 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00453154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453154.